FIRST AMENDMENT TO CLINICAL TRIAL COLLABORATION AGREEMENTClinical Trial Collaboration Agreement • August 13th, 2014 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances
This First Amendment to Clinical Trial Collaboration Agreement (this “Amendment”) is made and entered into as of June 15, 2014 (the “Amendment Effective Date”) and amends the Clinical Trial Collaboration Agreement dated April 18, 2013 (“Agreement”) between ARCA biopharma, Inc., a Delaware corporation (hereinafter “ARCA”), and Medtronic, Inc., a Delaware corporation (hereinafter “Medtronic”) (collectively, the “Parties”).
